Literature DB >> 33490285

Associations between Vascular Endothelial Growth Factor Gene Polymorphisms and Different Types of Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis.

Liming Hu1,2,3, Chunmei Gong1, Xiaoping Chen4, Honghao Zhou4, Junxia Yan2,3, Wenxu Hong1.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) gene polymorphisms have been shown to be associated with the risk of diabetic retinopathy (DR), but the results were inconsistent. The aim of this study was to systematically assess the associations between VEGF gene polymorphisms and different types of DR (nonproliferative DR and proliferative DR).
METHODS: Electronic databases PubMed, Embase, Web of Science, CNKI, and WANFANG DATA were searched for articles on the associations between VEGF gene polymorphisms and different types of DR up to November 6, 2019. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated, and subgroup analyses were conducted by ethnicity. Sensitivity analysis was conducted to assess the stability of the results. Publication bias was assessed by using the Egger regression asymmetry test and visualization of funnel plots. A systematic review was conducted for polymorphisms with a high degree of heterogeneity (I 2 > 75%) or studied in only one study.
RESULTS: A total of 13 and 18 studies analyzed the associations between VEGF SNPs and nonproliferative DR (NPDR) as well as proliferative DR (PDR), respectively. There were significant associations between rs2010963 and NPDR in Asian (dominant model: OR = 1.29, 95%CI = 1.04 - 1.60); and rs2010963 is associated with PDR in total population (dominant model: OR = 1.20, 95%CI = 1.03 - 1.41), either Asian (recessive model: OR = 1.57, 95%CI = 1.04 - 2.35) or Caucasian (recessive model: OR = 1.83, 95%CI = 1.28 - 2.63). Rs833061 is associated with PDR in Asian (recessive model: OR = 1.58, 95%CI = 1.11 - 2.26). Rs699947 is associated with NPDR in the total population (dominant model: OR = 2.04, 95%CI = 1.30 - 3.21) and associated with PDR in Asian (dominant model: OR = 1.72, 95%CI = 1.05 - 2.84).
CONCLUSIONS: Rs2010963, rs833061, and rs699947 are associated with NPDR or PDR, which may be involved in the occurrence and development of DR.
Copyright © 2021 Liming Hu et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33490285      PMCID: PMC7805525          DOI: 10.1155/2021/7059139

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  45 in total

1.  Association of vascular endothelial growth factor -634G/C and receptor for advanced glycation end products G82S gene polymorphisms with diabetic retinopathy.

Authors:  Asmaa Kamal; Khaled Abu Eleinen; Ibrahem Siam
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 2.  Associations between diabetic retinopathy and systemic risk factors.

Authors:  N Wat; R Lm Wong; I Yh Wong
Journal:  Hong Kong Med J       Date:  2016-10-24       Impact factor: 2.227

3.  Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic vascular complications in type 2 diabetes mellitus.

Authors:  Agnieszka Gala-Błądzińska; Joanna Czech; Marcin Braun; Marzena Skrzypa; Krzysztof Gargasz; Artur Mazur; Izabela Zawlik
Journal:  Adv Med Sci       Date:  2019-01-15       Impact factor: 3.287

4.  Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.

Authors:  T Kangas-Kontio; S Vavuli; S J Kakko; J Penna; E-R Savolainen; M J Savolainen; M Johanna Liinamaa
Journal:  Br J Ophthalmol       Date:  2009-07-23       Impact factor: 4.638

5.  Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta-analysis.

Authors:  Xiu-Jing Xie; Yun-Mei Yang; Jiu-Kun Jiang; Yuan-Qiang Lu
Journal:  J Diabetes       Date:  2016-11-14       Impact factor: 4.006

6.  Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort.

Authors:  Satagopan Uthra; Rajiv Raman; Bickol N Mukesh; Samuel A Rajkumar; Kumari R Padmaja; Pradeep G Paul; Praveena Lakshmipathy; Perumal Gnanamoorthy; Tarun Sharma; Catherine A McCarty; Govindasamy Kumaramanickavel
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

7.  Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a cross-sectional study.

Authors:  Xiaohong Fan; Qunhong Wu; Yuan Li; Yanhua Hao; Ning Ning; Zheng Kang; Yu Cui; Ruohong Liu; Liyuan Han
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

Review 8.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

Review 9.  The quality of meta-analyses of genetic association studies: a review with recommendations.

Authors:  Cosetta Minelli; John R Thompson; Keith R Abrams; Ammarin Thakkinstian; John Attia
Journal:  Am J Epidemiol       Date:  2009-11-09       Impact factor: 4.897

10.  Diabetic retinopathy: Battling the global epidemic.

Authors:  Arup Das
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

View more
  2 in total

Review 1.  Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Authors:  Ashay D Bhatwadekar; Aumer Shughoury; Ameya Belamkar; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.141

Review 2.  Contribution of Müller Cells in the Diabetic Retinopathy Development: Focus on Oxidative Stress and Inflammation.

Authors:  Raul Carpi-Santos; Ricardo A de Melo Reis; Flávia Carvalho Alcantara Gomes; Karin C Calaza
Journal:  Antioxidants (Basel)       Date:  2022-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.